By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.
Peter Attia MD#97 – Peter Hotez, M.D., Ph.D.: COVID-19: transmissibility, vaccines, risk reduction, and treatment
Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.
At a glance
WHAT IT’S REALLY ABOUT
Dr. Hotez Explains COVID-19 Transmissibility, Convalescent Serum, Vaccine Hurdles, and Mid-March Risks
- Hotez says SARS-CoV-2 is dangerous because it is both highly transmissible and seriously fatal for certain groups, while kids and young adults can spread it without getting very sick.
- He argues the US lost weeks of opportunity because testing lagged, letting transmission go undetected and raising the risk of overwhelmed hospitals and depleted healthcare and first-responder workforces.
- Hotez promotes convalescent serum, an idea from Arturo Casadevall, as a low-cost treatment and prophylaxis that could be available long before antivirals or vaccines.
- He explains that a vaccine will be slow partly because of safety standards and the risk of immune enhancement seen with earlier RSV and SARS vaccine work, and says his team's already-manufactured receptor binding domain vaccine still lacks funding for clinical trials.
- Both speakers stress uncertainty, noting that modes of transmission, seasonality and model projections are poorly understood and that information is changing weekly.
IDEAS WORTH REMEMBERING
5 ideasThe virus is dangerous because of the combination of moderate-to-high lethality and high transmissibility.
Hotez contrasts it with SARS 1 and MERS, whose severely ill patients were not out spreading the virus; here many mildly affected people, including kids, circulate and infect vulnerable groups.
Delayed testing let transmission run undetected.
Hotez cites Marc Lipsitch's work comparing Wuhan, where transmission went six weeks before intervention, with Guangdong, which acted after about a week, and worries US hospitals could be inundated within weeks.
Healthcare workforce losses cascade beyond their raw numbers.
Hotez notes that healthcare workers and first responders are getting infected and must quarantine, and Attia adds that losing 10 to 15 percent of staff hurts care capacity far more than proportionally.
Convalescent serum could be the one tool available soon.
Hotez says it is relatively low-tech, might need roughly 300 to 600 mL per seriously ill patient but only about 5 mL for prophylaxis, though it would need blood bank, apheresis and FDA/CBER coordination.
A coronavirus vaccine faces both timeline and safety hurdles.
Vaccines are given to healthy people so the safety bar is high, and earlier RSV and SARS vaccine experiments showed immune enhancement, which is why Hotez's team focused on the receptor binding domain.
WORDS WORTH SAVING
5 quotesWhile it isn't necessarily the most lethal virus we've ever seen, nor is it the most transmissible, it's high in both categories, and that combines in this very unique way.
— Dr. Peter Hotez
So the point is we've had a new coronavirus pandemic every decade of this 21st century.
— Dr. Peter Hotez
I think the best weapon against ignorance and false information is the kinds of things that you're doing.
— Dr. Peter Hotez
We've somehow decided that engaging public audiences is not important.
— Dr. Peter Hotez
new pathogens in general set you up to look stupid because, you know, when you're trying to learn something about a new pathogen, but this one especially because it's so fast-moving and transmissible, I would cringe if I were to look at my interviews from two or three weeks ago
— Dr. Peter Hotez
High quality AI-generated summary created from speaker-labeled transcript.
